Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron and metoclopramide versus placebo for severe nausea and vomiting in pregnancy
ISRCTN16924692Phase 3Terminated
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Feb 2018
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ondansetron and metoclopramide in nausea and vomiting of pregnancy (NVP) (4 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Treatment failure. Started Feb 2018; status: terminated.
02
Drugs
ondansetronmetoclopramide
03
Conditions
nausea and vomiting of pregnancy (NVP)
Beyond the preview
Go deeper on ISRCTN16924692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16924692.